[Clinical evaluation of tetraaolean: comparative studies with tetracycline]

Area of Science:

• Clinical pharmacology
• Infectious diseases
• Respiratory medicine

Background:

• Acute and exacerbated respiratory organ infections pose a significant public health challenge.
• Antibiotic resistance necessitates the evaluation of alternative therapeutic agents.
• Comparative studies are crucial for determining optimal treatment strategies.

Purpose of the Study:

• To compare the clinical effectiveness of tetraolean and tetracycline in treating respiratory infections.
• To evaluate the therapeutic outcomes in patients with pneumonia and endocarditis lenta.
• To investigate the potential synergistic mechanisms of tetraolean.

Main Methods:

• Comparative clinical studies involving 1672 patients with acute and exacerbated respiratory infections.
• Analysis of objective indices to assess therapeutic efficacy.
• Inclusion of patients with pneumonia and endocarditis lenta.

Main Results:

• Tetraolean showed statistically significant superiority over tetracycline in treating respiratory infections.
• Positive therapeutic effects were observed in 14 patients with endocarditis lenta.
• The study identified a "clinical synergism" associated with tetraolean's superior effect.

Conclusions:

• Tetraolean is a more effective therapeutic agent than tetracycline for respiratory infections.
• Tetraolean may offer benefits in treating complex conditions like endocarditis lenta.
• Further research into the "clinical synergism" of tetraolean is warranted.